Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_assertion type Assertion NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_head.
- NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_assertion description "[A significant reduction in MeCP2 expression compared to age-matched controls was found in 11/14 autism (79%), 9/9 RTT (100%), 4/4 Angelman syndrome (100%), 3/4 Prader-Willi syndrome (75%), 3/5 Down syndrome (60%), and 2/2 attention deficit hyperactivity disorder (100%) frontal cortex samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_provenance.
- NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_assertion evidence source_evidence_literature NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_provenance.
- NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_assertion SIO_000772 17486179 NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_provenance.
- NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_assertion wasDerivedFrom befree-20150227 NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_provenance.
- NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_assertion wasGeneratedBy ECO_0000203 NP552051.RAhM-uml3mvi5WfWPxSowspChkkF67EZbS2rx37xRQaLE130_provenance.